Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06844305 · ClinicalTrials.gov registry record · NA

Personalized Prosthetic Foot Prescription and Rehabilitation for Veterans With Lower Limb Loss

A NA study, sponsored by Northwestern University.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT06844305: Clinical Trial NA study, sponsored by Northwestern University.

NCT06844305 is a NA study that has not yet begun recruiting, run by Northwestern University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06844305, a NA study, has not yet begun recruiting, sponsored by Northwestern University.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of clinical trial is to assess an integrated, patient-centered strategy combining user preference-based prosthetic foot prescription and subsequent targeted physical therapy to maximize satisfaction and mobility outcomes for Veterans and others with lower limb loss. The main aims it will address are: * Assess the effect of prosthetic foot selection based on experiential preference as determined using a variable stiffness foot on mobility and satisfaction * Assess the effect of a targeted physical therapy intervention following preference-based foot selection on mobility, balance, and satisfaction? Participants will walk with an emulator prosthetic foot to experience three different conditions that emulate different commercial feet to determine their most- and least-preferred foot. Participants' satisfaction, perceived mobility, and functional mobility will be measured and compared between their most- and least-preferred feet using the corresponding commercial feet. Participants will then be randomly assigned to receive either the standard-of-care (control group) or personalized physical therapy intervention for eight weeks using that preferred prosthetic foot. Participants' satisfaction, mobility, and balance will be measured pre- and post-intervention.

Primary Outcome

Patient-reported outcome measure that assesses functional satisfaction with the prosthesis. The maximum value is 15 and the minimum value is 5, with higher better scores meaning a better outcome. This sum score (max 15) is used for reporting and analysis.

Interventions

  • OTHER Physical therapy
  • OTHER Prosthetic foot

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-12
Est. Completion 2029-05
Phase NA
Northwestern University

1,209 total trials

What is known before NCT06844305 opens enrollment

NCT06844305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Physical therapy is the first listed.

NCT06844305 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06844305 about?

NCT06844305 is a clinical study titled "Personalized Prosthetic Foot Prescription and Rehabilitation for Veterans With Lower Limb Loss". The goal of clinical trial is to assess an integrated, patient-centered strategy combining user preference-based prosthetic foot prescription and subsequent targeted physical therapy to maximize satisfaction and mobility outcomes for Veterans and others with lower limb loss. The main aims it will ad...

What is the current status of trial NCT06844305?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-12. Estimated completion is 2029-05.

What interventions are being tested in trial NCT06844305?

The interventions under investigation include: Physical therapy (OTHER), Prosthetic foot (OTHER).

Who is sponsoring clinical trial NCT06844305?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06844305's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06844305, the US trial registry maintained by the National Library of Medicine. NCT06844305 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.